Panel Discussion

kconnect.genesolutions.com interactive case discussions beyond high risk features can ctdna redefine adjuvant decision making in stage ii colon cancer cover presentation 8 - The K-CONNECT Platform
Download
Download is available until [expire_date]
  • Version
  • Download 0
  • File Size 4.00 KB
  • File Count 1
  • Create Date August 7, 2026
  • Last Updated August 7, 2026

Panel Discussion

Prof. Ho Gwo Fuang (Chairperson), Curie OncologyMalaysia

Dr. Lan Tu, Gene Solutions.

Prof. Dr Shaheenah Dawood, Mediclinic Middle East, UAE​.

Dr. Nguyen Duy Sinh, Gene Solutions.

Dr. Christina Lai Nye Bing, Hospital Picaso, Malaysia​.

 

<iframe width="1840" height="1035" src="https://www.youtube.com/embed/uonZz_ALTBQ" title="Panel Discussion | Precision Oncology Academy 2026 – Gene Solutions Malaysia" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>

Speaker:
kconnect.genesolutions.com interactive case discussions beyond high risk features can ctdna redefine adjuvant decision making in stage ii colon cancer cover presentation 8 - The K-CONNECT Platform

Panel Discussion and Q&A

Precision Oncology Academy 2026

K-CONNECT APAC 2025